Assessment of Disease Control Status in Hypertension and Type 2 Diabetes Mellitus Patients Coming for Medication Report Renewal and Home Blood Pressure Measurement Habits in Hypertension Patients

Öz

Objective: In this study, the disease control status of patients who came to renew their medication reports was compared with that of patients who visited for follow-up, and home blood pressure measurement habits were evaluated in hypertensive patients. Materials and Methods: The records of outpatients who visited the Internal Medicine Outpatient Clinic-13 of Adana Yüreğir State Hospital between 1 January and 14 February 2025 were retrospectively reviewed. A total of 1,774 patient files were screened, and 389 patients with hypertension and 367 patients with type 2 diabetes were identified. Patients were divided into two groups based on their reason for presentation: those who came to renew their medication prescriptions and those who came for follow-up. Hypertension was considered controlled if systolic blood pressure was <130 mmHg and diastolic blood pressure was <80 mmHg. Type 2 diabetes was considered controlled in patients with fasting blood sugar ≤130 mg/dl and HbA1c ≤7%. Results: 36.8% of hypertension patients came to renew their medication reports, and 15.9% came for follow-up. The habit of measuring blood pressure at home was 34.3% in the report renewal group and 54.8% in the control group (p<0.05). Hypertension control was similar and low in both groups (28.7% and 27.5%, p=0.85). Among patients with type 2 diabetes, 36.5% applied for report renewal and 23.4% for follow-up. The rate of diabetes control was 30.6% in the report renewal group and 39.5% in the follow-up group (p=0.172). Conclusion: The rates of follow-up visit attendance and disease control were low in both disease groups and most patients visited the hospital only to get a medication report.

Anahtar Kelimeler

• Hypertension
• Type 2 Diabetes
• Home blood pressure monitoring

İlaç Raporu Yenilemeye Gelen Hipertansiyon ve Tip 2 Diabetes Mellitus Hastalarında Hastalık Kontrol Durumları ile Hipertansiyon Hastalarında Evde Kan Basıncı Ölçme Alışkanlıklarının Değerlendirilmesi

Öz

Yöntem: Adana Yüreğir Devlet Hastanesi İç Hastalıkları Polikliniği-13’e 01 Ocak - 14 Şubat 2025 tarihleri arasında ayaktan başvuran hastaların kayıtları retrospektif olarak incelendi. Toplam 1774 hasta dosyası tarandı, 389 hipertansiyon ve 367 tip 2 diyabet hastası tespit edildi. Hastalar başvuru nedenlerine göre ilaç raporu yenilemek için gelenler ve kontrol için gelenler olarak iki gruba ayrıldı. Hipertansiyon için sistolik kan basıncı <130 mmHg ve diyastolik kan basıncı <80 mmHg olanların hastalığı kontrol altında kabul edildi. Tip 2 Diyabet için açlık kan şekeri ≤130 mg/dl ve HbA1c ≤%7 olanların hastalığı kontrol altında kabul edildi Bulgular: Hipertansiyon hastalarının %36,8'i ilaç raporu yenileme, %15,9'u kontrol amacıyla başvurmuştu. Evde kan basıncı ölçümü alışkanlığı rapor yenileme grubunda %34,3, kontrol grubunda %54,8 idi (p<0,05). Hipertansiyonun kontrol altında olması her iki grupta da benzer ve düşük bulundu (%28,7 ve %27,5, p=0,85). Tip 2 diyabet hastalarının %36,5'i rapor yenileme, %23,4'ü kontrol için başvurmuştu. Diyabet için kontrol altında olma oranı rapor yenileme grubunda %30,6, kontrol grubunda %39,5 idi (p=0,172). Sonuç: Her iki hastalık grubunda da takip ziyaretlerine katılım ve hastalık kontrol oranları düşüktü ve çoğu hasta sadece ilaç raporu almak için hastaneye başvurduğu görüldü.

Anahtar Kelimeler

• Hipertansiyon
• Tip 2 Diyabet
• Evde kan basıncı takibi

Kaynakça

1. Sosyal Güvenlik Kurumu. Sağlık Uygulama Tebliği. Resmî Gazete. 2013;(28597):17229. Erişim tarihi: 7 Haziran 2025. https://mevzuat.gov.tr/mevzuat?MevzuatNo=17229&MevzuatTur=9&MevzuatTertip=5
2. Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol. 2013;28(2):169-180. Crossref
3. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary. Hypertension. 2018;71(6):1269-1324. Crossref
4. Türkiye Endokrinoloji ve Metabolizma Derneği. Hipertansiyon Tanı ve Tedavi Kılavuzu 2022. 6. baskı. Ankara:
5. Türkiye Endokrinoloji ve Metabolizma Derneği Obezite, Dislipidemi, Hipertansiyon Çalışma Grubu; 2022.
6. McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912-4018. Crossref
7. Sengul S, Akpolat T, Erdem Y, Derici U, Arici M, Sindel S, et al. Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012. J Hypertens. 2016;34(6):1208-1217. Crossref
8. Abaci A, Oguz A, Kozan O, Toprak N, Senocak H, Deger N, et al. Treatment and control of hypertension in Turkish population: a survey on high blood pressure in primary care (the TURKSAHA study). J Hum Hypertens. 2006;20(5):355-361. Crossref

9. T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. Kronik Hastalıklar ve Yaşlı Sağlığı Daire Başkanlığı Dokümanlar. Erişim tarihi: 7 Haziran 2025. https://hsgm.saglik.gov.tr/tr/dokumanlar-kronikhastaliklar.html
10. Türkiye Endokrinoloji ve Metabolizma Derneği Diyabet Bilimsel Çalışma Grubu. Diabetes Mellitus ve Komplikasyonlarının Tanı, Tedavi ve İzlem Kılavuzu 2024. 16. baskı. Ankara: Türkiye Endokrinoloji ve Metabolizma Derneği; 2024. Erişim tarihi: 26 Haziran 2024. https://file.temd.org.tr/Uploads/publications/guides/documents/diabetesmellitus2024.pdf
11. McManus RJ, Little P, Stuart B, Morton K, Raftery J, Kelly J, et al; HOME BP Investigators. Home and online management and evaluation of blood pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial. BMJ. 2021;372:m4858. Crossref
12. Andraos J, Munjy L, Kelly MS. Home blood pressure monitoring to improve hypertension control: a narrative review of international guideline recommendations. Blood Press. 2021;30(4):220-229. Crossref
13. Choudhry NK, Kronish IM, Vongpatanasin W, Ferdinand KC, Pavlik VN, Egan BM, et al; American Heart Association Council on Hypertension; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology. Medication adherence and blood pressure control: a scientific statement from the American Heart Association. Hypertension. 2022;79(1):e1-e14. Crossref
14. Mahmood S, Jalal Z, Hadi MA, Shah KU. Association between attendance at outpatient follow-up appointments and blood pressure control among patients with hypertension. BMC Cardiovasc Disord. 2020;20(1):458. Crossref
15. Huang QF, Yang WY, Asayama K, Zhang ZY, Thijs L, Li Y, et al. Ambulatory blood pressure monitoring to diagnose and manage hypertension. Hypertension. 2021;77(2):254-264. Crossref
16. Gondi S, Ellis S, Gupta M, Ellerbeck E, Richter K, Burns J, et al. Physician perceived barriers and facilitators for self-measured blood pressure monitoring: a qualitative study. PLoS One. 2021;16(8):e0255578. Crossref
17. Dhungana RR, Pedisic Z, de Courten M. Implementation of non-pharmacological interventions for the treatment of hypertension in primary care: a narrative review of effectiveness, cost-effectiveness, barriers, and facilitators. BMC Prim Care. 2022;23(1):298. Crossref
18. Bin Rakhis SA Sr, AlDuwayhis NM, Aleid N, AlBarrak AN, Aloraini AA. Glycemic control for type 2 diabetes mellitus patients: a systematic review. Cureus. 2022;14(6):e26180. Crossref
19. Zhao Q, Li H, Ni Q, Dai Y, Zheng Q, Wang Y, et al. Follow-up frequency and clinical outcomes in patients with type 2 diabetes: a prospetive analysis based on multicenter real-world data. J Diabetes. 2022;14(5):306-314. Crossref
20. Sugimoto K, Ikegami H, Takata Y, Katsuya T, Fukuda M, Akasaka H, et al. Glycemic control and insulin improve muscle mass and gait speed in type 2 diabetes: the MUSCLES-DM study. J Am Med Dir Assoc. 2021;22(4):834-838. Crossref
21. Hurst CP, Rakkapao N, Hay K. Impact of diabetes self-management, diabetes management self-efficacy and diabetes knowledge on glycemic control in people with type 2 diabetes (T2D): a multi-center study in Thailand. PLoS One. 2020;15(12):e0244692. Crossref
22. Koo BK, Moon S, Moon MK. Muscle strength, an independent determinant of glycemic control in older adults with long-standing type 2 diabetes: a prospective cohort study. BMC Geriatr. 2021;21(1):684. Crossref
23. Kosjerina V, Parsa M, Scheuer SH, Ankarfeldt MZ, Sørensen KK, Brock B, et al. Comparative cardiovascular effectiveness of newer glucose-lowering drugs in elderly with type 2 diabetes: a target trial emulation cohort study. Lancet Reg Health Eur. 2025;40:100923. Crossref